SNNAQ — Sienna Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Sienna Biopharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2015 December 31st	2016 December 31st	2017 December 31st	2018 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash
Cash and Short Term Investments	4.96	9.09	74.5	48.5
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5.64	10.5	77.3	50.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.114	0.291	0.432	0.311
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	5.75	62.4	137	107
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.01	9.88	8.24	24.3
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1.7	40.3	45.6	80.7
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	4.05	22.1	91.2	26.6
Total Liabilities & Shareholders' Equity	5.75	62.4	137	107
Total Common Shares Outstanding